<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8"><meta name="viewport" content="width=device-width, initial-scale=1.0"><meta name="apple-mobile-web-app-capable" content="yes">
    <title>üéß Endocrinology Study Guide ‚Äî Audio Edition</title>
    <style>
        :root { --primary: #7c3aed; --primary-light: #a78bfa; --accent: #e07b53; --bg: #1a1a2e; --card-bg: #16213e; --text: #e8e8e8; --text-muted: #a0a0a0; --border: #2d3a4f; }
        * { box-sizing: border-box; margin: 0; padding: 0; }
        body { font-family: -apple-system, sans-serif; background: var(--bg); color: var(--text); line-height: 1.8; padding: 20px; padding-bottom: 200px; font-size: 18px; }
        .header { text-align: center; padding: 30px 20px; background: linear-gradient(135deg, var(--primary), var(--primary-light)); border-radius: 16px; margin-bottom: 20px; }
        .header h1 { font-size: 1.5rem; margin-bottom: 8px; }
        .audio-controls { position: fixed; bottom: 0; left: 0; right: 0; background: rgba(22,33,62,0.98); padding: 15px 20px; padding-bottom: max(15px, env(safe-area-inset-bottom)); border-top: 1px solid var(--border); z-index: 1000; }
        .controls-row { display: flex; align-items: center; justify-content: center; gap: 15px; margin-bottom: 10px; }
        .control-btn { background: var(--primary); border: none; color: white; width: 50px; height: 50px; border-radius: 50%; font-size: 1.3rem; cursor: pointer; display: flex; align-items: center; justify-content: center; }
        .control-btn.play-btn { width: 65px; height: 65px; font-size: 1.6rem; background: var(--accent); }
        .progress-section { display: flex; align-items: center; gap: 10px; font-size: 0.8rem; color: var(--text-muted); }
        .progress-bar { flex: 1; height: 6px; background: var(--border); border-radius: 3px; cursor: pointer; }
        .progress-fill { height: 100%; background: var(--accent); width: 0%; }
        .current-topic { text-align: center; font-size: 0.85rem; color: var(--accent); margin-top: 8px; }
        .settings-row { display: flex; justify-content: center; gap: 20px; margin-top: 10px; }
        .speed-control select, .pause-control select { background: var(--card-bg); color: var(--text); border: 1px solid var(--border); padding: 6px 10px; border-radius: 8px; }
        .section { background: var(--card-bg); border-radius: 12px; margin-bottom: 20px; }
        .section-header { background: var(--primary); padding: 15px 20px; font-size: 1.1rem; font-weight: 600; display: flex; justify-content: space-between; }
        .section-content { padding: 20px; }
        .topic { margin-bottom: 25px; padding-bottom: 20px; border-bottom: 1px solid var(--border); }
        .topic:last-child { border-bottom: none; }
        .topic-title { font-size: 1.1rem; font-weight: 600; color: var(--accent); margin-bottom: 15px; }
        .content-block { margin-bottom: 15px; padding: 15px; background: rgba(255,255,255,0.03); border-radius: 8px; border-left: 3px solid var(--primary); }
        .content-block.high-yield { border-left-color: #ef4444; background: rgba(239, 68, 68, 0.1); }
        .block-label { font-size: 0.75rem; text-transform: uppercase; color: var(--text-muted); margin-bottom: 8px; }
        .current { background: rgba(124, 58, 237, 0.3); border-radius: 3px; }
        .voice-selector { margin: 15px 0; padding: 15px; background: var(--card-bg); border-radius: 12px; }
        .voice-selector select { width: 100%; padding: 10px; background: var(--bg); color: var(--text); border: 1px solid var(--border); border-radius: 8px; }
        .toc { background: var(--card-bg); border-radius: 12px; padding: 20px; margin-bottom: 20px; }
        .toc-item { padding: 10px 15px; margin: 5px 0; background: rgba(255,255,255,0.03); border-radius: 8px; cursor: pointer; display: flex; justify-content: space-between; }
        .toc-item.active { background: var(--primary); }
    </style>
</head>
<body>
<div class="header"><h1>ü¶ã Endocrinology Study Guide</h1><p>Audio Edition ‚Ä¢ ABIM Board Review ‚Ä¢ 8% of Exam</p><p style="font-size:0.8rem; opacity:0.7; margin-top:8px;">v1.0 BUILD #8</p></div>
<div class="voice-selector"><label>üéôÔ∏è Voice:</label><select id="voiceSelect"></select></div>
<div class="toc"><h2>üìã Chapters</h2>
    <div class="toc-item" data-section="0"><span>1. Diabetes Mellitus</span><span>~8 min</span></div>
    <div class="toc-item" data-section="1"><span>2. DKA & HHS</span><span>~6 min</span></div>
    <div class="toc-item" data-section="2"><span>3. Thyroid Disorders</span><span>~7 min</span></div>
    <div class="toc-item" data-section="3"><span>4. Adrenal Disorders</span><span>~6 min</span></div>
    <div class="toc-item" data-section="4"><span>5. Pituitary & Calcium</span><span>~6 min</span></div>
</div>
<div id="audioContent">
<div class="section" data-section="0">
    <div class="section-header"><span>1. Diabetes Mellitus</span><span>‚ñ∂Ô∏è</span></div>
    <div class="section-content">
        <div class="topic"><div class="topic-title">Diagnosis</div>
            <div class="content-block"><div class="block-label">Diagnostic Criteria</div>
                <p class="speakable">Diabetes is diagnosed by fasting glucose 126 or higher, 2-hour glucose 200 or higher during OGTT, HbA1c 6.5 percent or higher, or random glucose 200 or higher with symptoms.</p>
                <p class="speakable">Two abnormal tests are required for diagnosis unless random glucose with symptoms.</p>
                <p class="speakable">Prediabetes is fasting glucose 100 to 125, HbA1c 5.7 to 6.4, or 2-hour glucose 140 to 199.</p>
            </div>
        </div>
        <div class="topic"><div class="topic-title">Treatment Goals</div>
            <div class="content-block high-yield"><div class="block-label">Glycemic Targets</div>
                <p class="speakable">General A1c goal is less than 7 percent for most adults.</p>
                <p class="speakable">More stringent goal of less than 6.5 is appropriate for younger patients without hypoglycemia risk.</p>
                <p class="speakable">Less stringent goal of less than 8 is appropriate for elderly, limited life expectancy, or hypoglycemia-prone patients.</p>
            </div>
            <div class="content-block high-yield"><div class="block-label">Medication Selection</div>
                <p class="speakable">Metformin remains first-line unless contraindicated.</p>
                <p class="speakable">For patients with ASCVD, heart failure, or CKD, add SGLT2 inhibitor or GLP-1 receptor agonist regardless of A1c.</p>
                <p class="speakable">SGLT2 inhibitors reduce heart failure hospitalizations and CKD progression. Examples are empagliflozin and dapagliflozin.</p>
                <p class="speakable">GLP-1 agonists reduce cardiovascular events and promote weight loss. Examples are semaglutide, liraglutide, and dulaglutide.</p>
            </div>
        </div>
    </div>
</div>
<div class="section" data-section="1">
    <div class="section-header"><span>2. DKA & HHS</span><span>‚ñ∂Ô∏è</span></div>
    <div class="section-content">
        <div class="topic"><div class="topic-title">DKA Management</div>
            <div class="content-block high-yield"><div class="block-label">Key Points</div>
                <p class="speakable">DKA is defined by glucose over 250, pH less than 7.3 or bicarb less than 18, and positive ketones with anion gap acidosis.</p>
                <p class="speakable">Treatment priorities are fluids first, then insulin, then potassium.</p>
                <p class="speakable">Start with IV normal saline 1 to 1.5 liters per hour initially, then adjust based on hemodynamics.</p>
                <p class="speakable">Hold insulin if potassium is less than 3.3. Replete potassium first.</p>
                <p class="speakable">Continue IV insulin until anion gap closes, not just until glucose normalizes. Add dextrose to fluids when glucose falls below 200.</p>
                <p class="speakable">Overlap subcutaneous insulin with IV insulin by 1 to 2 hours before stopping the drip.</p>
            </div>
        </div>
        <div class="topic"><div class="topic-title">HHS</div>
            <div class="content-block"><div class="block-label">Distinguishing Features</div>
                <p class="speakable">HHS presents with glucose over 600, osmolality over 320, minimal ketones, and pH above 7.3.</p>
                <p class="speakable">Patients are profoundly dehydrated, often with 8 to 10 liter deficits.</p>
                <p class="speakable">Fluid resuscitation is even more critical in HHS than DKA. Start with 1 to 2 liters per hour initially.</p>
            </div>
        </div>
    </div>
</div>
<div class="section" data-section="2">
    <div class="section-header"><span>3. Thyroid Disorders</span><span>‚ñ∂Ô∏è</span></div>
    <div class="section-content">
        <div class="topic"><div class="topic-title">Hypothyroidism</div>
            <div class="content-block"><div class="block-label">Diagnosis and Treatment</div>
                <p class="speakable">Primary hypothyroidism shows elevated TSH with low free T4. Most common cause is Hashimoto's thyroiditis.</p>
                <p class="speakable">Treat with levothyroxine. Full replacement dose is approximately 1.6 micrograms per kilogram.</p>
                <p class="speakable">In elderly and cardiac patients, start with lower doses and titrate slowly.</p>
                <p class="speakable">Goal TSH is generally 0.5 to 2.5 for most patients.</p>
            </div>
        </div>
        <div class="topic"><div class="topic-title">Hyperthyroidism</div>
            <div class="content-block high-yield"><div class="block-label">Causes and Workup</div>
                <p class="speakable">Graves' disease is the most common cause. It presents with diffuse goiter and positive TSI antibodies.</p>
                <p class="speakable">Toxic multinodular goiter and toxic adenoma show increased uptake on thyroid scan.</p>
                <p class="speakable">Thyroiditis and exogenous thyroid hormone show low or absent uptake on scan.</p>
                <p class="speakable">Treatment options for Graves' include antithyroid drugs methimazole or PTU, radioactive iodine, or surgery.</p>
                <p class="speakable">PTU is preferred in first trimester pregnancy due to methimazole teratogenicity.</p>
            </div>
        </div>
        <div class="topic"><div class="topic-title">Thyroid Storm</div>
            <div class="content-block high-yield"><div class="block-label">Emergency Management</div>
                <p class="speakable">Thyroid storm is a life-threatening complication of hyperthyroidism with fever, tachycardia, altered mental status, and multiorgan dysfunction.</p>
                <p class="speakable">Treatment requires PTU to block synthesis, iodine given 1 hour after PTU to block release, beta-blocker for rate control, and steroids.</p>
                <p class="speakable">Give iodine only after PTU to prevent using iodine as substrate for more hormone synthesis.</p>
            </div>
        </div>
    </div>
</div>
<div class="section" data-section="3">
    <div class="section-header"><span>4. Adrenal Disorders</span><span>‚ñ∂Ô∏è</span></div>
    <div class="section-content">
        <div class="topic"><div class="topic-title">Adrenal Insufficiency</div>
            <div class="content-block high-yield"><div class="block-label">Diagnosis</div>
                <p class="speakable">Primary adrenal insufficiency, or Addison's disease, presents with fatigue, hypotension, hyperpigmentation, hyponatremia, and hyperkalemia.</p>
                <p class="speakable">Secondary adrenal insufficiency from pituitary disease lacks hyperpigmentation and hyperkalemia.</p>
                <p class="speakable">Morning cortisol less than 3 confirms diagnosis. Cortisol above 18 excludes it. Intermediate values need ACTH stimulation test.</p>
                <p class="speakable">Cosyntropin stimulation test: give 250 micrograms IV, measure cortisol at 30 and 60 minutes. Peak cortisol above 18 is normal.</p>
            </div>
            <div class="content-block"><div class="block-label">Treatment</div>
                <p class="speakable">Replacement is hydrocortisone 15 to 25 milligrams daily in divided doses.</p>
                <p class="speakable">Primary AI also requires fludrocortisone for mineralocorticoid replacement.</p>
                <p class="speakable">Stress dosing: double or triple dose for illness. Give IV hydrocortisone 100 milligrams for surgery or adrenal crisis.</p>
            </div>
        </div>
        <div class="topic"><div class="topic-title">Cushing Syndrome</div>
            <div class="content-block"><div class="block-label">Diagnosis</div>
                <p class="speakable">Clinical features include central obesity, moon facies, buffalo hump, striae, thin skin, proximal weakness, and hypertension.</p>
                <p class="speakable">Screening tests: 24-hour urine free cortisol, late-night salivary cortisol, or 1 milligram overnight dexamethasone suppression test.</p>
                <p class="speakable">If screening positive, measure ACTH. ACTH-dependent causes are pituitary adenoma or ectopic ACTH. ACTH-independent causes are adrenal tumors.</p>
            </div>
        </div>
    </div>
</div>
<div class="section" data-section="4">
    <div class="section-header"><span>5. Pituitary & Calcium</span><span>‚ñ∂Ô∏è</span></div>
    <div class="section-content">
        <div class="topic"><div class="topic-title">Hypercalcemia</div>
            <div class="content-block high-yield"><div class="block-label">Causes and Management</div>
                <p class="speakable">Most common causes are primary hyperparathyroidism and malignancy.</p>
                <p class="speakable">PTH will be elevated or inappropriately normal in hyperparathyroidism, and suppressed in malignancy.</p>
                <p class="speakable">Treatment of acute symptomatic hypercalcemia: IV saline for volume expansion, then loop diuretics. Calcitonin for rapid but short-lived effect. Bisphosphonates for sustained effect but take 2 to 4 days.</p>
                <p class="speakable">Denosumab is an alternative to bisphosphonates, especially in renal impairment.</p>
            </div>
        </div>
        <div class="topic"><div class="topic-title">Pituitary Adenomas</div>
            <div class="content-block"><div class="block-label">Management</div>
                <p class="speakable">Prolactinoma is the most common pituitary tumor. Treat medically with dopamine agonists cabergoline or bromocriptine.</p>
                <p class="speakable">Growth hormone-secreting adenomas cause acromegaly. Surgery is first-line.</p>
                <p class="speakable">Nonfunctioning adenomas are monitored if small. Surgery for visual field defects or significant mass effect.</p>
            </div>
        </div>
    </div>
</div>
</div>
<div class="audio-controls">
    <div class="controls-row"><button class="control-btn" onclick="skipBackward()">‚è™</button><button class="control-btn play-btn" id="playPauseBtn" onclick="togglePlayPause()">‚ñ∂Ô∏è</button><button class="control-btn" onclick="skipForward()">‚è©</button><button class="control-btn" onclick="stopReading()">‚èπÔ∏è</button></div>
    <div class="progress-section"><span id="currentTime">0:00</span><div class="progress-bar" onclick="seekTo(event)"><div class="progress-fill" id="progressFill"></div></div><span id="totalTime">0:00</span></div>
    <div class="current-topic" id="currentTopic">Ready to play</div>
    <div class="settings-row"><div class="speed-control"><label>Speed:</label><select id="speedSelect" onchange="updateSpeed()"><option value="0.75">0.75√ó</option><option value="1" selected>1√ó</option><option value="1.5">1.5√ó</option><option value="2">2√ó</option></select></div><div class="pause-control"><label>Pauses:</label><select id="pauseSelect" onchange="updatePauses()"><option value="short">Short</option><option value="medium" selected>Medium</option><option value="long">Long</option></select></div></div>
</div>
<script>
let isPlaying=false,currentSentenceIndex=0,sentences=[],speechRate=1,englishVoices=[],pauseSettings={sentence:400,paragraph:800,section:1500};
document.addEventListener('DOMContentLoaded',()=>{loadVoices();buildSentenceList();setupTOC();const s=localStorage.getItem('endo_audio_pos');if(s)currentSentenceIndex=parseInt(s)||0;});
function loadVoices(){const sel=document.getElementById('voiceSelect');function pop(){const all=speechSynthesis.getVoices();englishVoices=all.filter(v=>v.lang.startsWith('en-'));if(!englishVoices.length){setTimeout(pop,100);return;}sel.innerHTML='';englishVoices.forEach((v,i)=>{const o=document.createElement('option');o.value=i;o.textContent=`${v.localService?'‚≠ê ':''}${v.name}`;sel.appendChild(o);});}pop();speechSynthesis.onvoiceschanged=pop;}
function buildSentenceList(){sentences=[];document.querySelectorAll('.speakable').forEach((el,i,arr)=>{const sec=el.closest('.section'),top=el.closest('.topic');sentences.push({text:el.textContent.trim(),element:el,section:sec?parseInt(sec.dataset.section):0,topic:top?.querySelector('.topic-title')?.textContent||'',isNewBlock:i===0||el.closest('.content-block')!==arr[i-1]?.closest('.content-block'),isNewSection:i===0||(sec?.dataset.section!==arr[i-1]?.closest('.section')?.dataset.section)});});updateProgress();}
function setupTOC(){document.querySelectorAll('.toc-item').forEach(item=>{item.addEventListener('click',()=>jumpToSection(parseInt(item.dataset.section)));});}
function jumpToSection(idx){const i=sentences.findIndex(s=>s.section===idx);if(i!==-1){currentSentenceIndex=i;if(isPlaying){speechSynthesis.cancel();speakCurrentSentence();}updateProgress();}}
function togglePlayPause(){isPlaying?pauseReading():startReading();}
function startReading(){isPlaying=true;document.getElementById('playPauseBtn').textContent='‚è∏Ô∏è';speakCurrentSentence();}
function pauseReading(){isPlaying=false;speechSynthesis.cancel();document.getElementById('playPauseBtn').textContent='‚ñ∂Ô∏è';localStorage.setItem('endo_audio_pos',currentSentenceIndex);}
function stopReading(){isPlaying=false;speechSynthesis.cancel();currentSentenceIndex=0;document.getElementById('playPauseBtn').textContent='‚ñ∂Ô∏è';updateProgress();localStorage.removeItem('endo_audio_pos');}
function speakCurrentSentence(){if(!isPlaying||currentSentenceIndex>=sentences.length){if(currentSentenceIndex>=sentences.length)stopReading();return;}const s=sentences[currentSentenceIndex],u=new SpeechSynthesisUtterance(s.text),vi=parseInt(document.getElementById('voiceSelect').value)||0;if(englishVoices[vi])u.voice=englishVoices[vi];u.lang='en-US';u.rate=speechRate;document.querySelectorAll('.current').forEach(el=>el.classList.remove('current'));s.element.classList.add('current');s.element.scrollIntoView({behavior:'smooth',block:'center'});document.getElementById('currentTopic').textContent=s.topic;updateProgress();u.onend=()=>{currentSentenceIndex++;if(currentSentenceIndex<sentences.length){let p=pauseSettings.sentence;if(sentences[currentSentenceIndex].isNewSection)p=pauseSettings.section;else if(sentences[currentSentenceIndex].isNewBlock)p=pauseSettings.paragraph;setTimeout(()=>{if(isPlaying)speakCurrentSentence();},p);}else stopReading();};speechSynthesis.speak(u);}
function updateProgress(){const pct=sentences.length?(currentSentenceIndex/sentences.length)*100:0;document.getElementById('progressFill').style.width=pct+'%';const avg=3/speechRate;document.getElementById('currentTime').textContent=Math.floor(currentSentenceIndex*avg/60)+':'+(Math.floor(currentSentenceIndex*avg)%60).toString().padStart(2,'0');document.getElementById('totalTime').textContent=Math.floor(sentences.length*avg/60)+':'+(Math.floor(sentences.length*avg)%60).toString().padStart(2,'0');}
function seekTo(e){currentSentenceIndex=Math.floor((e.offsetX/e.currentTarget.offsetWidth)*sentences.length);if(isPlaying){speechSynthesis.cancel();speakCurrentSentence();}updateProgress();}
function skipForward(){currentSentenceIndex=Math.min(currentSentenceIndex+10,sentences.length-1);if(isPlaying){speechSynthesis.cancel();speakCurrentSentence();}updateProgress();}
function skipBackward(){currentSentenceIndex=Math.max(currentSentenceIndex-10,0);if(isPlaying){speechSynthesis.cancel();speakCurrentSentence();}updateProgress();}
function updateSpeed(){speechRate=parseFloat(document.getElementById('speedSelect').value);updateProgress();}
function updatePauses(){const s=document.getElementById('pauseSelect').value;pauseSettings=s==='short'?{sentence:200,paragraph:400,section:800}:s==='long'?{sentence:600,paragraph:1200,section:2000}:{sentence:400,paragraph:800,section:1500};}
</script>
</body>
</html>
